Suppr超能文献

通过甲胎蛋白测定评估肝癌化疗效果。

Evaluation of hepatoma chemotherapy by alpha-fetoprotein determination.

作者信息

Matsumoto Y, Suzuki T, Ono H, Nakase A, Honjo I

出版信息

Am J Surg. 1976 Sep;132(3):325-8. doi: 10.1016/0002-9610(76)90385-8.

Abstract

Effects of chemotherapy on twenty-nine histologically proved and alpha-fetoprotein (AFP) -positive hepatomas were evaluated by changes in serum AFP levels according to the criteria of our previous report. By transfemoral local infusion of mitomycin C, six of eight patients showed more than 50 per cent decrease of AFP levels and regression of the tumor, and the others showed fair effects. By single shot infusion, 50 per cent decrease of serum AFP levels and tumor regression were noted only in three of thirteen patients, and chemotherapy by systemic infusion in eight patients was much less effective. As evaluated by AFP levels, histologically well or moderately differentiated hepatocellular carcinomas responded better to chemotherapy than poorly differentiated ones.

摘要

根据我们之前报告的标准,通过血清甲胎蛋白(AFP)水平的变化来评估化疗对29例经组织学证实且AFP呈阳性的肝癌的疗效。通过经股动脉局部注入丝裂霉素C,8例患者中有6例AFP水平下降超过50%且肿瘤消退,其他患者显示出一定疗效。通过单次注射,13例患者中只有3例血清AFP水平下降50%且肿瘤消退,8例患者进行全身注入化疗的效果要差得多。根据AFP水平评估,组织学上高分化或中分化的肝细胞癌比低分化的肝细胞癌对化疗反应更好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验